Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,587.44
(
-0.56%
)
US TECH 100
23,626.40
(
-0.71%
)
Dow Jones
45,914.09
(
-0.67%
)
Brent Oil
107.51
(
0.87%
)
Bitcoin
69,473.89
(
-2.48%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 3718

Thursday, 09/23/2004 11:42:24 PM

Thursday, September 23, 2004 11:42:24 PM

Post# of 257259
>> cybx is just sooooo stupid <<

They are without a doubt the laughing stock of biotech. Did they really think investors wouldn’t be able to distinguish between (conditional) approval to run an expanded-access trial and (conditional) approval of the product for marketing?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now